Hepatoprotective effects of whey protein on D-galactosamine-induced hepatitis and liver fibrosis in rats

Bioscience, Biotechnology and Biochemistry

Volumn 70, Issue 5, 2006, Pages 1281-1285

  Kume, Hisae ^a   Okazaki, Keiko ^a   Sasaki, Hajime ^a  

^a MEIJI DAIRIES CORPORATION   (Japan)

Author keywords

Bile duct proliferation; D galactosamine; Fibrosis; Hepatitis; Whey protein

Indexed keywords

BIOLOGICAL ORGANS; BIOMARKERS; DISEASES; ENZYME KINETICS; NUTRITION;

BILE DUCT PROLIFERATION; D-GALACTOSAMINE; FIBROSIS; WHEY PROTEIN;

PROTEINS;

ALANINE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; GALACTOSAMINE; HYALURONIC ACID; LACTATE DEHYDROGENASE; MILK PROTEIN; PROTECTIVE AGENT; WHEY PROTEIN;

ANIMAL; ARTICLE; BLOOD; CHEMICALLY INDUCED DISORDER; DIET; ELEMENTAL DIET; LIVER CIRRHOSIS; MALE; PATHOLOGY; RAT; SPRAGUE DAWLEY RAT; TOXIC HEPATITIS;

ALANINE; ANIMALS; ASPARTATE AMINOTRANSFERASES; BILIRUBIN; DIET; FOOD, FORMULATED; GALACTOSAMINE; HEPATITIS, TOXIC; HYALURONIC ACID; L-LACTATE DEHYDROGENASE; LIVER CIRRHOSIS; MALE; MILK PROTEINS; PROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 33646806138     PISSN: 09168451     EISSN: 13476947     Source Type: Journal    
DOI: 10.1271/bbb.70.1281     Document Type: Article

References (25)

1. Marshall, K., Therapeutic applications of whey protein. Altern. Med. Rev., 9, 136-156 (2004).
2. Hara, K., Ikeda, M., Saito, S., Matsumoto, S., Numata, K., Kato, N., Tanaka, K., and Sekihara, H., Lactoferrin inhibits hepatitis B virus infection in cultured human hepatocytes. Hepatol. Res., 24, 228 (2002).
3. Ikeda, M., Sugiyama, K., Tanaka, T., Tanaka, K., Sekihara, H., Shimotohno, K., and Kato, N., Lactoferrin markedly inhibits hepatitis C virus infection in cultured human hepatocytes. Biochem. Biophys. Res. Commun., 245, 549-553 (1998).
4. Tanaka, K., Ikeda, M., Nozaki, A., Kato, N., Tsuda, H., Saito, S., and Sekihara, H., Lactoferrin inhibits hepatitis C virus viremia in patients with chronic hepatitis C: a pilot study. Jpn. J. Cancer Res., 90, 367-371 (1999).
5. Yamaguchi, M., Matsuura, M., Kobayashi, K., Sasaki, H., Yajima, T., and Kuwata, T., Lactoferrin protects against development of hepatitis caused by sensitization of Kupffer cells by lipopolysaccharide. Clin. Diagn. Lab. Immunol., 8, 1234-1239 (2001).
6. Haversen, L., Ohlsson, B. G., Hahn-Zoric, M., Hanson, L. A., and Mattsby-Baltzer, I., Lactoferrin down-regulates the LPS-induced cytokine production in monocytic cells via NF-kappa B. Cell Immunol., 220, 83-95 (2002).
7. Mattsby-Baltzer, I., Roseanu, A., Motas, C., Elverfors, J., Engberg, I., and Hanson, L. A., Lactoferrin or a fragment there of inhibits the endotoxin-induced interleukin-6 response in human monocytic cells. Pediatr. Res., 40, 257-262 (1996).
8. Watanabe, A., Okada, K., Shimizu, Y., Wakabayashi, H., Higuchi, K., Niiya, K., Kuwabara, Y., Yasuyama, T., Ito, H., Tsukishiro, T., Kondoh, Y., Emi, N., and Kohri, H., Nutritional therapy of chronic hepatitis by whey protein (non-heated). J. Med., 31, 283-302 (2000).
9. Keppler, D., Lesch, R., Reutter, W., and Decker, K., Experimental hepatitis induced by D-galactosamine. Exp. Mol. Pathol., 9, 279-290 (1968).
10. Jonker, A. M., Dijkhuis, F. W., Kroese, F. G., Hardonk, M. J., and Grond, J., Immunopathology of acute galactosamine hepatitis in rats. Hepatology, 11, 622-627 (1990).
11. Jonker, A. M., Dijkhuis, F. W., Boes, A., Hardonk, M. J., and Grond, J., Immunohistochemical study of extracellular matrix in acute galactosamine hepatitis in rats. Hepatology, 15, 423-431 (1992).
12. Decker, K., and Keppler, D., Galactosamine hepatitis: key role of the nucleotide deficiency period in the pathogenesis of cell injury and cell death. Rev. Physiol. Biochem. Pharmacol., 71, 77-106 (1974).
13. Decker, K., Mechanisms and mediators in hepatic necrosis. Gastroenterol. Jpn., 28, 20-25, discussion 33-35 (1993).
14. Funatsu, K., Ishii, H., Shigeta, Y., Morita, A., and Tsuchiya, M., D-galactosamine induced hepatic cirrhosis: its ultrastructural and biochemical studies in rat. Acta Hepatogastroenterol (Stuttgart), 25, 97-104 (1978).
15. Jonker, A. M., Dijkhuis, F. W., Hardonk, M. J., Moerkerk, P., Ten Kate, J., and Grond, J., Immunohistochemical study of hepatic fibrosis induced in rats by multiple galactosamine injections. Hepatology, 19, 775-781 (1994).
16. Lesch, R., Keppler, D., Reutter, W., Rudigier, J., Oehlert, W., and Decker, K., Development of experimental liver cirrhosis by D-galactosamine: histological, biochemical and autoradiographic studies in rats. Virchows Arch. B Cell Pathol., 6, 57-71 (1970).
17. Eng, F. J., Friedman, S. L., and Fibrogenesis, I., New insights into hepatic stellate cell activation: the simple becomes complex. Am. J. Physiol. Gastrointest. Liver Physiol., 279, G7-G11 (2000).
18. Pinzani, M., and Rombouts, K., Liver fibrosis: from the bench to clinical targets. Dig. Liver Dis., 36, 231-242 (2004).
19. Schaefer, B., Rivas-Estilla, A. M., Meraz-Cruz, N., Reyes-Romero, M. A., Hernandez-Nazara, Z. H., Dominguez-Rosales, J. A., Schuppan, D., Greenwel, P., and Rojkind, M., Reciprocal modulation of matrix metalloproteinase-13 and type I collagen genes in rat hepatic stellate cells. Am. J. Pathol., 162, 1771-1780 (2003).
20. Sudo, K., Yamada, Y., Moriwaki, H., Saito, K., and Seishima, M., Lack of tumor necrosis factor receptor type 1 inhibits liver fibrosis induced by carbon tetrachloride in mice. Cytokine, 29, 236-244 (2005).
21. Tracey, K. J., Beutler, B., Lowry, S. F., Merryweather, J., Wolpe, S., Milsark, I. W., Hariri, R. J., Fahey, T. J., 3rd, Zentella, A., Albert, J. D., Shires, G. T., and Cerami, A., Shock and tissue injury induced by recombinant human cachectin. Science, 234, 470-474 (1986).
22. Wakabayashi, G., Gelfand, J. A., Jung, W. K., Connolly, R. J., Burke, J. F., and Dinarello, C. A., Staphylococcus epidermidis induces complement activation, tumor necrosis factor and interleukin-1, a shock-like state and tissue injury in rabbits without endotoxemia: Comparison to Escherichia coli. J. Clin. Invest., 87, 1925-1935 (1991).
23. Shito, M., Balis, U. J., Tompkins, R. G., Yarmush, M. L., and Toner, M., A fulminant hepatic failure model in the rat: involvement of interleukin-1 beta and tumor necrosis factor-alpha. Dig. Dis. Sci., 46, 1700-1708 (2001).
24. Lozano, J. M., Padillo, J., Montero, J. L., Pena, J., De la Mata, M., and Muntane, J., Immunomodulatory activity of TNF-alpha during acute liver injury induced by D-galactosamine and its protection by PGE1 in rats. Int. Immunopharmacol., 3, 197-207 (2003).
25. Galanos, C., Freudenburg, M. A., and Reutter, W., Galactosamine-induced sensitization to the lethal effects of endotoxin. Proc. Natl. Acad. Sci. USA, 76, 5939-5943 (1979).